Related references
Note: Only part of the references are listed.Cross Talk between inhibitory immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Receptor Pathways in Macrophages and Dendritic Cells
Ivan Hirsch et al.
FRONTIERS IN IMMUNOLOGY (2017)
Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology
Jean-Vianney Haure-Mirande et al.
ACTA NEUROPATHOLOGICA (2017)
Innate lymphoid cells: A new paradigm in immunology
Gerard Eberl et al.
SCIENCE (2015)
Innate lymphoid cells - a proposal for uniform nomenclature
Hergen Spits et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Role of ITAM signaling module in signal integration
Jelena S. Bezbradica et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Spleen tyrosine kinases: biology, therapeutic targets and drugs
Mauro Riccaboni et al.
DRUG DISCOVERY TODAY (2010)
Syk-coupled C-type lectin receptors that mediate cellular activation via single tyrosine based activation motifs
Ann M. Kerrigan et al.
IMMUNOLOGICAL REVIEWS (2010)
ITAM Receptor Signaling and the NLRP3 Inflammasome in Antifungal Immunity
Hendrik Poeck et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
TREM and TREM-like receptors in inflammation and disease
Jill W. Ford et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Resveratrol and Piceatannol Inhibit iNOS Expression and NF-kappa B Activation in Dextran Sulfate Sodium-Induced Mouse Colitis
Jin Youn et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2009)
Emerging drugs for rheumatoid arthritis
Paraskevi V. Voulgari
EXPERT OPINION ON EMERGING DRUGS (2008)
Activating and inhibitory functions of DAP12
Isaiah R. Turnbull et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs
Attila Mocsai et al.
NATURE IMMUNOLOGY (2006)
The TREM receptor family and signal integration
Julia Klesney-Tait et al.
NATURE IMMUNOLOGY (2006)
Pharmacokinetics of selected stilbenes:: rhapontigenin, piceatannol and pinosylvin in rats
Kathryn A. Roupe et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Tumor necrosis factor inhibitors for rheumatoid arthritis
D. L. Scott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions
E Tomasello et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Targeting Syk as a treatment for allergic and and autoimmune disorders
BR Wong et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)
Immunoblockade of PSGL-1 attenuates established experimental murine colitis by reduction of leukocyte rolling
EM Rijcken et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Modulation of hepatic granulomatous responses by transgene expression of DAP12 or TREM-1-lg molecules
H Nochi et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Piceatannol inhibits TNF-induced NF-κB activation and NF-κB-mediated gene expression through suppression of IκBα kinase and p65 phosphorylation
K Ashikawa et al.
JOURNAL OF IMMUNOLOGY (2002)
Importance of innate immunity and collagen binding integrin α1β1 in TNBS-induced colitis
S Fiorucci et al.
IMMUNITY (2002)
Syk expression and novel function in a wide variety of tissues
S Yanagi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function
LL Lanier et al.
IMMUNOLOGY TODAY (2000)
DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming
ABH Bakker et al.
IMMUNITY (2000)
Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice
E Tomasello et al.
IMMUNITY (2000)
Share Paper
